Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Sell
29
LMT Quote, Financials, Valuation and Earnings
Last price:
$439.74
Seasonality move
:
4.5%
Day range:
$432.51 - $481.50
52-week range:
$419.70 - $618.95
Dividend yield:
2.93%
P/E ratio:
19.75x
P/S ratio:
1.48x
P/B ratio:
16.34x
Volume:
7.1M
Avg. volume:
1.8M
1-year change:
-0.78%
Market cap:
$103.5B
Revenue:
$71B
EPS (TTM):
$22.26
Analysts' Opinion
-
Consensus RatingLockheed Martin has received a consensus rating of Hold. The company's average rating is a Hold based on 8 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $544.62, Lockheed Martin has an estimated upside of 23.86% from its current price of $439.70.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $418.00 representing 4.94% downside risk from its current price of $439.70.
Fair Value
-
According to the consensus of 19 analysts, Lockheed Martin has 23.86% upside to fair value with a price target of $544.62 per share.
LMT vs. S&P 500
-
Over the past 5 trading days, Lockheed Martin has underperformed the S&P 500 by -6.16% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lockheed Martin does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lockheed Martin revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Lockheed Martin reported revenues of $18.6B.
Earnings Growth
-
Lockheed Martin earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Lockheed Martin reported earnings per share of $2.22.
Enterprise value:
121.3B
EV / Invested capital:
--
Price / LTM sales:
1.48x
EV / EBIT:
16.72x
EV / Revenue:
1.71x
PEG ratio (5yr expected):
18.13x
EV / Free cash flow:
22.94x
Price / Operating cash flow:
19.90x
Enterprise value / EBITDA:
13.76x
Gross Profit (TTM):
$6.9B
Return On Assets:
9.75%
Net Income Margin (TTM):
7.51%
Return On Equity:
80.38%
Return On Invested Capital:
20.7%
Operating Margin:
3.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $66B | $67.6B | $71B | $18.9B | $18.6B | |
| Gross Profit | $8.3B | $8.5B | $6.9B | $2.3B | $690M | |
| Operating Income | $8.3B | $8.6B | $7B | $2.3B | $696M | |
| EBITDA | $8.7B | $10.4B | $8.8B | $2.8B | $1.2B | |
| Diluted EPS | $21.71 | $27.55 | $22.26 | $7.58 | $2.22 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $19.4B | $19.8B | $21B | $20.5B | $21.8B | |
| Total Assets | $50.7B | $50.9B | $52.9B | $52.5B | $55.6B | |
| Current Liabilities | $13.9B | $14B | $15.9B | $16.9B | $19.4B | |
| Total Liabilities | $44.7B | $39.9B | $43.6B | $45.6B | $49.3B | |
| Total Equity | $6B | $11B | $9.3B | $6.8B | $6.3B | |
| Total Debt | $12.2B | $11.7B | $15.5B | $17.5B | $20.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $7.8B | $7.9B | $7B | $2.4B | $1B | |
| Cash From Investing | -$1.8B | -$1.7B | -$1.8B | -$703M | -$838M | |
| Cash From Financing | -$7.1B | -$7.3B | -$4.1B | -$3.8B | -$853M | |
| Free Cash Flow | $6.1B | $6.2B | $5.3B | $1.7B | $441M | |
LMT
Sector
Market Cap
$103.5B
$618.1M
Price % of 52-Week High
71.04%
74.1%
Dividend Yield
2.93%
0%
Shareholder Yield
5.37%
2.42%
1-Year Price Total Return
-0.78%
-6.88%
Beta (5-Year)
0.432
0.889
Dividend yield:
2.93%
Annualized payout:
$12.75
Payout ratio:
57.33%
Growth streak:
22 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$463.69
200-day SMA
Sell
Level
$512.29
Bollinger Bands (100)
Sell
Level
453.17 - 531.87
Chaikin Money Flow
Buy
Level
303.3M
20-day SMA
Sell
Level
$456.92
Relative Strength Index (RSI14)
Sell
Level
37.90
ADX Line
Sell
Level
20.56
Williams %R
Buy
Level
-88.345
50-day SMA
Sell
Level
$461.66
MACD (12, 26)
Buy
Level
1.04
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
145.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.5109)
Sell
CA Score
(Annual)
Level (-1.0794)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (0.9951)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Aeronautics is Lockheed’s largest segment, which derives upward of two-thirds of its revenue from the F-35. Lockheed’s remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.
Stock Forecast FAQ
In the current month, LMT has received 8 Buy ratings 11 Hold ratings, and 0 Sell ratings. The LMT average analyst price target in the past 3 months is $544.62.
-
Where Will Lockheed Martin Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lockheed Martin share price will rise to $544.62 per share over the next 12 months.
-
What Do Analysts Say About Lockheed Martin?
Analysts are divided on their view about Lockheed Martin share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lockheed Martin is a Sell and believe this share price will drop from its current level to $418.00.
-
What Is Lockheed Martin's Price Target?
The price target for Lockheed Martin over the next 1-year time period is forecast to be $544.62 according to 19 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is LMT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lockheed Martin is a Hold. 11 of 19 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of LMT?
You can purchase shares of Lockheed Martin via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lockheed Martin shares.
-
What Is The Lockheed Martin Share Price Today?
Lockheed Martin was last trading at $439.74 per share. This represents the most recent stock quote for Lockheed Martin. Yesterday, Lockheed Martin closed at $439.70 per share.
-
How To Buy Lockheed Martin Stock Online?
In order to purchase Lockheed Martin stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
